相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment
Te-Ling Ma et al.
PLOS ONE (2019)
The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation Among Asian Patients With Chronic Hepatitis B: A Systematic Review
Jiaye Liu et al.
HEPATOLOGY (2019)
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B
George V. Papatheodoridis et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naive HBV-infected individuals
Hongxin Huang et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Current advances in the elimination of hepatitis B in China by 2030
Shuye Zhang et al.
FRONTIERS OF MEDICINE (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
George Papatheodoridis et al.
HEPATOLOGY (2016)
HBV replication, pathobiology and therapy: Unanswered questions
Christoph Seeger et al.
JOURNAL OF HEPATOLOGY (2016)
Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the magic bullet to kill cccDNA
Ejuan Zhang et al.
ANTIVIRAL RESEARCH (2015)
Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection
Chien-Hung Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Wai-Kay Seto et al.
GUT (2015)
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
Stephane Chevaliez et al.
JOURNAL OF HEPATOLOGY (2013)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
GUT (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
Y. Liang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
Feng Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
Roeland Zoutendijk et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
分享论文
